196 related articles for article (PubMed ID: 29446998)
1. Considerations for Clinical Review of Cellular Therapy Products: Perspectives of the China Food and Drug Administration Center for Drug Evaluation.
Liu Y; Zhao C; Gao L; Yang H; He R; Gao C
Hum Gene Ther; 2018 Feb; 29(2):121-127. PubMed ID: 29446998
[TBL] [Abstract][Full Text] [Related]
2. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells.
Abken H
Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803
[TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptor T cell therapy: 25years in the making.
Gill S; Maus MV; Porter DL
Blood Rev; 2016 May; 30(3):157-67. PubMed ID: 26574053
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy: opportunities, risks and future perspectives.
Hildebrandt M; Peggs K; Uharek L; Bollard CM; Heslop HE
Cytotherapy; 2014 Apr; 16(4 Suppl):S120-9. PubMed ID: 24629797
[TBL] [Abstract][Full Text] [Related]
5. Driving cars to the clinic for solid tumors.
Castellarin M; Watanabe K; June CH; Kloss CC; Posey AD
Gene Ther; 2018 Jun; 25(3):165-175. PubMed ID: 29880908
[TBL] [Abstract][Full Text] [Related]
6. Adoptive T-cell therapy for cancer: The era of engineered T cells.
Bonini C; Mondino A
Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
[TBL] [Abstract][Full Text] [Related]
7. Sending CAR T Cells After Multiple Myeloma.
Cancer Discov; 2017 Aug; 7(8):OF9. PubMed ID: 28588060
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on chimeric antigen receptor engineered T cell research and clinical trials in China.
Luo C; Wei J; Han W
Sci China Life Sci; 2016 Apr; 59(4):349-59. PubMed ID: 27009301
[TBL] [Abstract][Full Text] [Related]
9. Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma.
Avanzi MP; Brentjens RJ
J Natl Compr Canc Netw; 2017 Nov; 15(11):1429-1437. PubMed ID: 29118234
[TBL] [Abstract][Full Text] [Related]
10. [Historical perspectives and future directions of gene-modified T-cell therapy].
Akatsuka Y
Rinsho Ketsueki; 2016; 57(10):2241-2249. PubMed ID: 27795536
[TBL] [Abstract][Full Text] [Related]
11. Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.
Wang X; Rivière I
Cancer Gene Ther; 2015 Mar; 22(2):85-94. PubMed ID: 25721207
[TBL] [Abstract][Full Text] [Related]
12. Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.
Kim MG; Kim D; Suh SK; Park Z; Choi MJ; Oh YK
Arch Pharm Res; 2016 Apr; 39(4):437-452. PubMed ID: 26895243
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.
Maus MV; Levine BL
Oncologist; 2016 May; 21(5):608-17. PubMed ID: 27009942
[TBL] [Abstract][Full Text] [Related]
14. Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy.
Fesnak AD; Hanley PJ; Levine BL
Curr Hematol Malig Rep; 2017 Aug; 12(4):335-343. PubMed ID: 28762038
[TBL] [Abstract][Full Text] [Related]
15. Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors.
Torikai H; Cooper LJ
Mol Ther; 2016 Aug; 24(7):1178-86. PubMed ID: 27203439
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress on Chimeric Antigen Receptor T Cells-Review].
Zhuang RM; Cheng J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1829-1832. PubMed ID: 29262925
[TBL] [Abstract][Full Text] [Related]
17. Driving T-cell immunotherapy to solid tumors.
Garber K
Nat Biotechnol; 2018 Mar; 36(3):215-219. PubMed ID: 29509745
[No Abstract] [Full Text] [Related]
18. Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer.
Magee MS; Snook AE
Discov Med; 2014 Nov; 18(100):265-71. PubMed ID: 25425467
[TBL] [Abstract][Full Text] [Related]
19. A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy.
Zhang E; Xu H
J Hematol Oncol; 2017 Jan; 10(1):1. PubMed ID: 28049484
[TBL] [Abstract][Full Text] [Related]
20. Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells.
Geyer MB; Brentjens RJ
Cytotherapy; 2016 Nov; 18(11):1393-1409. PubMed ID: 27592405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
